Form 4 for TYRA Tyra Biosciences, Inc.
Accepted 2024-03-19 00:00:00 ET · period of report 2024-03-15 · accession 0000950170-24-033848 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-19 | 2024-03-15 | TYRA | Fuhrman Alan | CFO | A - Grant | $12.48 | +932 | 2,395 | +64% | +$11.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-15 | A | A | 932 | $12.48 | 2,395 | D | — | — |